Aetiology : it occurs in patients with
HIV
infection
HHV-8 / KSHV+
immunoblasts with plasmacytoid cytoplasm
HHV-4 / EBV+
PELs (most) : these viral double positive cells harbour mutated rearranged
Ig genes, suggesting that they originate from germinal centre or post-germinal
centre B-cells. Within the KSHV+ PELs, the effect of EBV is
more subtle but nevertheless clearref
EBV- PELs may originate from either germinal/post-germinal centre
or naive B-cellsref
Lymphomatous effusions that lack KSHV also occur; these are frequently
EBV associated in the setting of HIV infection. Many genes, including cell
cycle and signal transduction regulators, are differentially expressed
between KSHV+ PELs and KSHV- lymphomatous effusions
and also between KSHV+, EBV+ and KSHV+,
EBV- PELs. KSHV plays an important role in the pathogenesis
of PELs, as its presence selects for a very distinct cellular gene expression
category and a clearly different lymphoma typeref.
Pathogenesis : PEL cells were able to produce
tumors and ascites very efficiently with infiltration of cells in various
organs of T-, B- and NK-cell knock-out NOD/SCID/gc(null)
(NOG) mice within 3 weeks. In contrast, PEL cells formed small tumors at
inoculated sites in T- and B-cell knock-out NOD/SCID mice with NK-cells
while completely failing to infiltrate into various organs. Immunosupression
of NOD/SCID by treatment with an antimurine TM-b1
antibody, which transiently abrogates NK cell activity in vivo, resulted
in enhanced tumorigenicity and organ infiltration in comparison with non-treated
NOD/SCID mice. Activated human NK cells inhibited tumor growth and infiltration
in NOG mice. NK cells play an important role in growth and infiltration
of PEL cells, and activated NK cells could be a promising immunotherapeutic
tool against tumor or virus-infected cells either alone or in combination
with conventional therapy. The rapid and efficient engraftment of PEL cells
in NOG mice also suggests that this new animal model could provide a unique
opportunity to understand and investigate the mechanism of pathogenesis
and malignant cell growthref Symptoms & signs : lymphomatous effusions
primarily in body cavities and occasionally extranodal sites without the
presence of a solid tumor
Laboratory examinations : the tumor cells
usually do not express immunoglobulin (Ig) and B-cell markers but express
syndecan-1 (CD138)ref
and harbor hypermutated rearranged immunoglobulin genesref,
suggesting that they originate from germinal center or postgerminal center
B cellsref